BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15792995)

  • 21. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
    Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
    Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.
    Gremmel T; Yanachkov IB; Yanachkova MI; Wright GE; Wider J; Undyala VV; Michelson AD; Frelinger AL; Przyklenk K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):501-9. PubMed ID: 26743169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain.
    Andó RD; Méhész B; Gyires K; Illes P; Sperlágh B
    Br J Pharmacol; 2010 Mar; 159(5):1106-17. PubMed ID: 20136836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
    Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
    Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
    Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
    Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2X1-mediated ERK2 activation amplifies the collagen-induced platelet secretion by enhancing myosin light chain kinase activation.
    Toth-Zsamboki E; Oury C; Cornelissen H; De Vos R; Vermylen J; Hoylaerts MF
    J Biol Chem; 2003 Nov; 278(47):46661-7. PubMed ID: 14500714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation.
    Huang Z; Liu P; Zhu L; Li N; Hu H
    Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo.
    Hechler B; Lenain N; Marchese P; Vial C; Heim V; Freund M; Cazenave JP; Cattaneo M; Ruggeri ZM; Evans R; Gachet C
    J Exp Med; 2003 Aug; 198(4):661-7. PubMed ID: 12913094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
    Paul BZ; Jin J; Kunapuli SP
    J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
    Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The P2 receptors in platelet function.
    Hechler B; Cattaneo M; Gachet C
    Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet P2 receptors: old and new targets for antithrombotic drugs.
    Cattaneo M
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen.
    Oury C; Toth-Zsamboki E; Vermylen J; Hoylaerts MF
    Blood; 2002 Oct; 100(7):2499-505. PubMed ID: 12239162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA; Mustard JF
    Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
    Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
    J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The platelet P2 receptors in arterial thrombosis.
    Gachet C; Léon C; Hechler B
    Blood Cells Mol Dis; 2006; 36(2):223-7. PubMed ID: 16466948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.